$1.33
-0.01-0.75%
Pre-Market: 6:56 AM EDT
Comments
Loading...
Dermata Therapeutics (NASDAQ:DRMA) Stock, Earnings Estimates, EPS, And Revenue
Dermata Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-2.040
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Dermata Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Dermata Therapeutics (DRMA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-2.04 | $-2.64 | 22.7 % |
| Jun 2024 | 2024-08-07 | $-4.18 | $-3.79 | -10.3 % |
| Mar 2024 | 2024-05-15 | $-7.05 | $-5.40 | -30.6 % |
| Sep 2023 | 2023-11-09 | $-8.10 | $-9.45 | 14.3 % |
Dermata Therapeutics (DRMA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Dermata Therapeutics (NASDAQ:DRMA) reporting earnings?
Dermata Therapeutics (DRMA) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Dermata Therapeutics (NASDAQ:DRMA)?
The Actual EPS was $-2.04, which beat the estimate of $-2.64.
What were Dermata Therapeutics’s (NASDAQ:DRMA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.